Annual Cash & Cash Equivalents
$25.45 M
-$34.09 M-57.25%
31 December 2022
Summary:
Calithera Biosciences annual cash & cash equivalents is currently $25.45 million, with the most recent change of -$34.09 million (-57.25%) on 31 December 2022. During the last 3 years, it has fallen by -$81.69 million (-76.25%). CALA annual cash & cash equivalents is now -76.25% below its all-time high of $107.15 million, reached on 31 December 2020.CALA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$25.45 M
-$8.62 M-25.29%
31 December 2022
Summary:
Calithera Biosciences quarterly cash and cash equivalents is currently $25.45 million, with the most recent change of -$8.62 million (-25.29%) on 31 December 2022. CALA quarterly cash and cash equivalents is now -78.89% below its all-time high of $120.58 million, reached on 30 September 2020.CALA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -76.3% | -69.9% |
| 5 y5 years | -50.1% | +17.5% |
CALA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.3% | at low | -69.9% | at low |
| 5 y | 5 years | -76.3% | at low | -78.9% | +17.5% |
| alltime | all time | -76.3% | +1054.2% | -78.9% | +316.9% |
Calithera Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $25.45 M(-57.3%) | $25.45 M(-25.3%) |
| Sept 2022 | - | $34.07 M(-18.5%) |
| June 2022 | - | $41.79 M(-6.4%) |
| Mar 2022 | - | $44.66 M(-25.0%) |
| Dec 2021 | $59.54 M(-44.4%) | $59.54 M(-29.5%) |
| Sept 2021 | - | $84.49 M(-8.4%) |
| June 2021 | - | $92.20 M(-9.0%) |
| Mar 2021 | - | $101.35 M(-5.4%) |
| Dec 2020 | $107.15 M(+77.3%) | $107.15 M(-11.1%) |
| Sept 2020 | - | $120.58 M(+4.9%) |
| June 2020 | - | $114.89 M(+183.9%) |
| Mar 2020 | - | $40.47 M(-33.0%) |
| Dec 2019 | $60.44 M(+18.4%) | $60.44 M(+179.0%) |
| Sept 2019 | - | $21.66 M(-71.8%) |
| June 2019 | - | $76.79 M(+89.2%) |
| Mar 2019 | - | $40.58 M(-20.5%) |
| Dec 2018 | $51.06 M | $51.06 M(-16.5%) |
| Sept 2018 | - | $61.13 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $55.87 M(+1.9%) |
| Mar 2018 | - | $54.84 M(+13.1%) |
| Dec 2017 | $48.48 M(+357.3%) | $48.48 M(+23.0%) |
| Sept 2017 | - | $39.41 M(-32.0%) |
| June 2017 | - | $58.00 M(-34.9%) |
| Mar 2017 | - | $89.07 M(+740.2%) |
| Dec 2016 | $10.60 M(+73.6%) | $10.60 M(-8.6%) |
| Sept 2016 | - | $11.60 M(+58.3%) |
| June 2016 | - | $7.33 M(-39.8%) |
| Mar 2016 | - | $12.17 M(+99.3%) |
| Dec 2015 | $6.11 M(-94.0%) | $6.11 M(-27.6%) |
| Sept 2015 | - | $8.43 M(-25.5%) |
| June 2015 | - | $11.32 M(-84.7%) |
| Mar 2015 | - | $73.88 M(-27.5%) |
| Dec 2014 | $101.97 M(+201.5%) | $101.97 M(+192.6%) |
| Sept 2014 | - | $34.85 M(+25.6%) |
| June 2014 | - | $27.75 M(-17.9%) |
| Dec 2013 | $33.82 M(+1433.8%) | $33.82 M |
| Dec 2012 | $2.21 M | - |
FAQ
- What is Calithera Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Calithera Biosciences?
- What is Calithera Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Calithera Biosciences?
What is Calithera Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CALA is $25.45 M
What is the all time high annual cash & cash equivalents for Calithera Biosciences?
Calithera Biosciences all-time high annual cash & cash equivalents is $107.15 M
What is Calithera Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CALA is $25.45 M
What is the all time high quarterly cash and cash equivalents for Calithera Biosciences?
Calithera Biosciences all-time high quarterly cash and cash equivalents is $120.58 M